Triptorelin Acetate
Triptorelin Acetate is a gonadotrophin releasing hormone (GnRH) blocker that stops the pituitary gland from producing luteinising hormone. It is used in the treatment of advanced prostate cancer and certain breast cancers by lowering testosterone/oestrogen levels.

Description
Product Introduction
Triptorelin is a gonadotrophin releasing hormone (GnRH) blocker. This means it stops messages from a part of the brain called the hypothalamus that tells the pituitary gland to produce luteinising hormone. Luteinising hormone tells the testicles to produce testosterone. So, blocking GnRH stops the testicles producing testosterone. Prostate cancer depends on testosterone to grow. So triptorelin can shrink the cancer or slow its growth. In women, it stops the ovaries from producing oestrogen. Some breast cancers depend on oestrogen to grow. Lowering the level of oestrogen can slow or stop the growth of the cancer.
Triptorelin is a GnRH agonist shown to inhibit estradiol-induced cancer cell proliferation. It is a modified (D-Trp6) LH-RH, useful in achieving medical castration in the treatment of advanced prostate cancer.
Product Description
- Application Field
- Prostate cancer treatment, gynecological diseases, assisted reproduction, peptide drug API
- Packaging
- Custom packaging per client requirements
- Storage Conditions
- -20°C, protected from light, sealed storage
- Shelf Life
- 2 years
Specifications
| Appearance | White to off-white powder |
| Purity (HPLC) | ≥98% |
| Peptide Content | ≥80% |




